Keryx Biopharmaceuticals (KERX) To Host Conference Call On Fourth Quarter And Year End 2013 Financial Results
3/12/2014 8:56:51 AM
NEW YORK, March 11, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Thursday, March 13, 2014 at 8:30 a.m. EDT to discuss results for the fourth quarter and year ended December 31, 2013 and a business outlook for 2014. Ron Bentsur, Chief Executive Officer of Keryx, will host the call.
Help employers find you! Check out all the jobs and post your resume.
comments powered by